Management ChangeOct 30, 2026, 04:07 PM
Tempest Therapeutics Appoints New CFO; Current CFO Departs
AI Summary
Tempest Therapeutics, Inc. announced a change in its Chief Financial Officer role. Constance Ames has resigned from her position as CFO and Principal Financial and Accounting Officer, effective immediately, citing personal considerations. The company has appointed Stephanie Horn-Warnock to fill these roles, along with Treasurer and Corporate Secretary. Ms. Horn-Warnock will serve as a consultant, compensated at an hourly rate of $450 plus expenses and an indirect cost allocation.
Key Highlights
- Constance Ames resigns as Chief Financial Officer and Principal Financial and Accounting Officer for personal reasons.
- Stephanie Horn-Warnock appointed as the new Chief Financial Officer, Principal Financial and Accounting Officer, Treasurer, and Corporate Secretary.
- Ms. Horn-Warnock will provide services as a consultant at a rate of $450 per hour plus expenses and a 5.0% indirect cost allocation.
Price Impact
More from TPST